Anti-GAD65; Anti GAD; AGAD; Glutamic Acid Decarboxylase-65 Antibodies
Back to Test Catalogue
Glutamic Acid Decarboxylase (GAD65) Antibodies, Serum
Test ID: GADAB S
Test
Aliases/Synonyms
Method
ELISA
Platform
Euroimmun Analyzer I
Report Includes
Glutamic Acid Decarboxylase (GAD65) Antibodies
Specimens
Serum
Clinical Utility
GAD65 antibodies are associated with systemic autoimmune diseases, including type 1 diabetes mellitus, thyroiditis and pernicious anemia. At high levels, they may be associated with neurological autoimmunity.
Test Version
25-Jul-2024
Specimen
Specimens
Serum
Collection Containers
Preferred
Gold top (clot activator & gel)
Acceptable
Red top (no additive)
Sample Volume
1 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 14 days |
| Frozen | 30 days |
Additional Stability Information
Freezing and thawing may lead to a loss of activity
Rejection Criteria
| Hemolysis | Present |
|---|---|
| Lipemia | Present |
| Specimen | Plasma |
Test Version
25-Jul-2024
Performance / Interpretation
Method
ELISA
Platform
Euroimmun Analyzer I
Turnaround Time
7 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Anti-GAD65 | IU/mL |
|
||
Test Version
25-Jul-2024
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| GADAB S | 63508Anti-GAD65 Elisa,Serum | IU/mL |
Test Version
25-Jul-2024